Financhill
Sell
1

SGD Quote, Financials, Valuation and Earnings

Last price:
$2.24
Seasonality move :
-48.14%
Day range:
$2.08 - $2.30
52-week range:
$1.45 - $53.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.40x
Volume:
9.5K
Avg. volume:
129.2K
1-year change:
-91.36%
Market cap:
$3.4M
Revenue:
--
EPS (TTM):
-$63.11
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $2.1M $3M
Other Inc / (Exp) -- -- -- -- $1.2K
Operating Expenses -- -- -- $2.1M $3M
Operating Income -- -- -- -$2.1M -$3M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$2.4M -$4.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$2.4M -$4.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$2.4M -$4.2M
 
Basic EPS (Cont. Ops) -- -- -- -$4.89 -$28.60
Diluted EPS (Cont. Ops) -- -- -- -$4.89 -$28.60
Weighted Average Basic Share -- -- -- $500K $146.6K
Weighted Average Diluted Share -- -- -- $500K $146.6K
 
EBITDA -- -- -- -$2.1M -$3M
EBIT -- -- -- -$2.1M -$3M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$2.1M -$3M
Operating Income (Adjusted) -- -- -- -$2.1M -$3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- $81.2K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- $192.9K $436.8K $584K $1.5M
Other Inc / (Exp) -- -- -- $320 --
Operating Expenses -- $192.9K $436.8K $584K $1.5M
Operating Income -- -$192.9K -$436.8K -$584K -$1.4M
 
Net Interest Expenses -- -- -- -- $951.2K
EBT. Incl. Unusual Items -- -$192.9K -$489K -$923.5K -$2.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -$491.3K -$923.5K -$2.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -$192.9K -$489K -$923.5K -$2.3M
 
Basic EPS (Cont. Ops) -- -$0.39 -$0.98 -$226.40 -$52.20
Diluted EPS (Cont. Ops) -- -$0.39 -$0.98 -$226.40 -$52.20
Weighted Average Basic Share -- $500K $500K $4.1K $44.8K
Weighted Average Diluted Share -- $500K $500K $4.1K $44.8K
 
EBITDA -- -$192.9K -$436.8K -$583.6K -$1.4M
EBIT -- -$192.9K -$436.8K -$583.7K -$1.4M
 
Revenue (Reported) -- -- -- -- $81.2K
Operating Income (Reported) -- -$192.9K -$436.8K -$584K -$1.4M
Operating Income (Adjusted) -- -$192.9K -$436.8K -$583.7K -$1.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- $1.5M $2.6M $6.2M
Other Inc / (Exp) -- -- -- $300 $900
Operating Expenses -- -- $1.5M $2.6M $6.2M
Operating Income -- -- -$1.5M -$2.6M -$6M
 
Net Interest Expenses -- -- -- -- $2.6M
EBT. Incl. Unusual Items -- -- -$1.7M -$3.6M -$9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$3.6M -$9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -$1.7M -$3.6M -$9M
 
Basic EPS (Cont. Ops) -- -- -$3.36 -$231.70 -$63.11
Diluted EPS (Cont. Ops) -- -- -$3.36 -$231.70 -$63.11
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -$1.5M -$2.6M -$6M
EBIT -- -- -$1.5M -$2.6M -$6M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -$1.5M -$2.6M -$6M
Operating Income (Adjusted) -- -- -$1.5M -$2.6M -$6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- $173.2K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- $192.9K $1.3M $1.8M $5M
Other Inc / (Exp) -- -- -- $320 --
Operating Expenses -- $192.9K $1.3M $1.8M $5M
Operating Income -- -$192.9K -$1.3M -$1.8M -$4.8M
 
Net Interest Expenses -- -- -- -- $2.6M
EBT. Incl. Unusual Items -- -$192.9K -$1.5M -$2.6M -$7.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -$1.5M -$2.6M -$7.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -$192.9K -$1.5M -$2.6M -$7.4M
 
Basic EPS (Cont. Ops) -- -$0.39 -$2.97 -$229.78 -$60.00
Diluted EPS (Cont. Ops) -- -$0.39 -$2.97 -$229.78 -$60.00
Weighted Average Basic Share -- $500K $1.5M $1M $1.4M
Weighted Average Diluted Share -- $500K $1.5M $1M $1.4M
 
EBITDA -- -$192.9K -$1.3M -$1.8M -$4.8M
EBIT -- -$192.9K -$1.3M -$1.8M -$4.8M
 
Revenue (Reported) -- -- -- -- $173.2K
Operating Income (Reported) -- -$192.9K -$1.3M -$1.8M -$4.8M
Operating Income (Adjusted) -- -$192.9K -$1.3M -$1.8M -$4.8M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents -- -- -- $720 $3.2K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- $25K $232K
Total Current Assets -- -- -- $25.8K $235.2K
 
Property Plant And Equipment -- -- $3.6M $1.2M $1.2M
Long-Term Investments -- -- $3.6M $3.6M $3.6M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- $670.1K $4.5M $4.5M
Total Assets -- -- $7.8M $9.3M $9.6M
 
Accounts Payable -- -- -- -- $601.3K
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- $4.2M $4.2M --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- $6.3M $7.1M $7.7M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- $6.3M $7.1M $7.7M
 
Common Stock -- -- -- -- $10.2K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- $1.5M $2.2M $1.9M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- $1.5M $2.2M $1.9M
 
Total Liabilities and Equity -- -- $7.8M $9.3M $9.6M
Cash and Short Terms -- -- -- $720 $3.2K
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- $33.4K $13.7K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- $417.9K $836.3K
Total Current Assets -- -- -- $451.3K $850K
 
Property Plant And Equipment -- -- $1.2M $1.2M $1.7M
Long-Term Investments -- -- $3.6M $3.6M $3.6M
Goodwill -- -- -- -- $1.8M
Other Intangibles -- -- -- -- $560.8K
Other Long-Term Assets -- -- $4.5M $4.5M $4.5M
Total Assets -- -- $9.2M $11.7M $13M
 
Accounts Payable -- -- -- -- $1.8M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- $4.2M $200K $8.2M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- $6.9M $7.1M $10.4M
 
Long-Term Debt -- -- -- -- $919.4K
Capital Leases -- -- -- -- --
Total Liabilities -- -- $6.9M $7.1M $12.2M
 
Common Stock -- -- -- $10K $940
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- $193K
Total Equity -- -- $2.4M $4.5M $820.9K
 
Total Liabilities and Equity -- -- $9.2M $11.7M $13M
Cash and Short Terms -- -- -- $33.4K $13.7K
Total Debt -- -- -- -- $9.1M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -- -- -- -$2.4M -$4.2M
Depreciation & Amoritzation -- -- -- -- $240
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- -$1.7M
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$2.3M -$4.6M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- -$42.7K
Cash From Investing -- -- -- -$1.4M -$59.6K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- $648.3K $6.2M
Long-Term Debt Repaid -- -- -- -- -$2.5M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- $3.7M $4.6M
 
Beginning Cash (CF) -- -- -- -- $720
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $720 $2.5K
Ending Cash (CF) -- -- -- $720 $3.2K
 
Levered Free Cash Flow -- -- -- -$3.7M -$4.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -$491.3K -$923.5K -$2.3M
Depreciation & Amoritzation -- -- -- $80 $1.4K
Stock-Based Compensation -- -- -- -- $58.4K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -$505.6K -$2.3M -$274.6K
 
Capital Expenditures -- -- -- -- $209.7K
Cash Acquisitions -- -- $162.4K -$17.7K --
Cash From Investing -- -- -$344.3K -$40.9K -$209.7K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $676.3K $1.2M $1.6M
Long-Term Debt Repaid -- -- -- -- -$526.3K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- $45K -$614.1K
Cash From Financing -- -- $849.9K $1.3M $473.8K
 
Beginning Cash (CF) -- -- -- $1.1M $24.2K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$1M -$10.5K
Ending Cash (CF) -- -- -- $33.4K $13.7K
 
Levered Free Cash Flow -- -- -$837.5K -$2.3M -$484.3K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$3.6M -$9M
Depreciation & Amoritzation -- -- -- $100 $2K
Stock-Based Compensation -- -- -- -- $2M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$5.3M -$1.6M
 
Capital Expenditures -- -- -- -- $241.6K
Cash Acquisitions -- -- -- -$42.7K $1.1K
Cash From Investing -- -- -- -$78.4K -$218.3K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- $6.6M $2.6M
Long-Term Debt Repaid -- -- -- -$2.5M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- -$1.1M
Cash From Financing -- -- -- $5.4M $1.8M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- -$19.7K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -$5.5M -$1.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -$1.5M -$2.6M -$7.4M
Depreciation & Amoritzation -- -- -- $80 $1.8K
Stock-Based Compensation -- -- -- -- $2M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -$1.6M -$4.6M -$1.5M
 
Capital Expenditures -- -- -- -- $241.7K
Cash Acquisitions -- -- -$0 -$42.7K $1.1K
Cash From Investing -- -- -$1.4M -$81.8K -$240.6K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $676.3K $6.7M $3.1M
Long-Term Debt Repaid -- -- -- -$2.5M -$526.3K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$441.8K -$1.5M
Cash From Financing -- -- $3M $4.7M $1.8M
 
Beginning Cash (CF) -- -- -- $2.4M $105K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $32.7K $10.5K
Ending Cash (CF) -- -- -- $2.5M $115.5K
 
Levered Free Cash Flow -- -- -$2.8M -$4.6M -$1.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock